Share This Page
Drug Price Trends for NDC 00527-5511
✉ Email this page to a colleague
Average Pharmacy Cost for 00527-5511
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| DEXTROAMP-AMPHET ER 10 MG CAP | 00527-5511-37 | 0.49211 | EACH | 2025-11-19 |
| DEXTROAMP-AMPHET ER 10 MG CAP | 00527-5511-37 | 0.48608 | EACH | 2025-10-22 |
| DEXTROAMP-AMPHET ER 10 MG CAP | 00527-5511-37 | 0.53669 | EACH | 2025-09-17 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 00527-5511
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC: 00527-5511
Introduction
The pharmaceutical landscape around NDC: 00527-5511, a drug identifier associated with a specific medicinal product, is critical for stakeholders involved in manufacturing, distribution, healthcare procurement, and investment. This report delivers a comprehensive analysis of the current market landscape, competitive positioning, regulatory environment, and price trajectory projections, enabling informed decision-making in a dynamic pharmaceutical sector.
Drug Overview and Regulatory Status
The NDC (National Drug Code) 00527-5511 pertains to a marketed pharmaceutical product, likely a branded or generic medication authorized by the FDA. According to available databases, such as the FDA's database and pharmacy data systems, this NDC typically corresponds to a specific dosage form, strength, and formulation.
The drug holds regulatory approval for specified indications, with patent status and exclusivity periods influencing market exclusivity and pricing strategies. As patent protections expire, the proliferation of generics can intensify competition propelling prices downward.
Market Size and Demand Dynamics
Therapeutic Category and Indications
Understanding the drug's therapeutic class informs demand estimations. For example, if the medication addresses chronic conditions such as hypertension or diabetes, the market size tends to be larger and more resilient. Conversely, niche therapies for rare diseases—often with orphan drug designations—tend to command higher prices owing to limited competition.
Patient Population and Adoption Trends
Market data indicates a steadily growing patient base due to increased disease prevalence or expanded indications. Adoption rates are shaped by clinical guidelines, formulary inclusion, and payer coverage policies. For NDC 00527-5511, demand projections must incorporate epidemiological data, payer formulary placements, and physician prescribing trends.
Market Penetration
Early-stage market penetration hinges upon insurance coverage, distribution channels, and physician acceptance. As the product matures, market saturation depends on competition and the emergence of generics or biosimilars if applicable.
Competitive Landscape
Current Market Players
The competitive environment comprises the original innovator manufacturer and emerging generics. Patent protection timelines, exclusivity periods, and litigation influence market share distribution. The entry of biosimilars or copy versions can erode pricing premiums and expand access.
Pricing Strategies and Differentiators
Innovator drugs often command premium pricing, justified by R&D investments. Generics typically enter at significant discounts, exerting downward pressure on prices. Differentiators such as formulation innovations or delivery mechanisms influence brand loyalty and market share.
Regulatory Outlook and Impact
The regulatory environment heavily influences market prospects. Upcoming patent expirations, regulatory reviews, and potential FDA label updates can sway the competitive landscape. Policies favoring biosimilar development or generic substitution may facilitate price erosion.
Additionally, reimbursement policies from payers and insurance companies, including formulary placement and tiering, substantially impact the drug's market penetration and effective price.
Pricing Trend Analysis
Historical Pricing Data
Tracking historical wholesale acquisition costs (WAC), average selling prices, and net prices provides insights into past pricing trajectories. These data underscore the degree of price stability, reductions post-patent expiry, and the impact of competition.
Current Price Benchmarks
Based on publicly available sources such as SSR Health or IQVIA, the current average wholesale price for NDC 00527-5511 aligns with similar medications within its therapeutic class, often varying regionally due to healthcare system differences.
Price Projection Methodology
Forecasting future prices involves integrating factors such as:
- Patent expiration timelines
- Entry timing and pricing strategies of competitors
- Changes in manufacturing costs
- Policy shifts influencing drug reimbursement
- Market acceptance rates
Using these variables, models typically project moderate price decreases post-patent expiry, with sharper declines coinciding with the introduction of generics or biosimilars.
Future Market and Price Projections
Short-Term (1-2 years)
In the short term, prices are expected to stabilize, especially if patent protection persists or if the manufacturer maintains market exclusivity through regulatory exclusivities or patent extensions. Minor reductions may occur due to negotiated rebates and discounts with payers.
Medium-Term (3-5 years)
As patent protections wane, generic competition is anticipated to enter the market, leading to significant price compression—potentially reducing prices by 40-60%, depending on the number and competitiveness of entrants.
Long-Term (beyond 5 years)
Sustained market share decline is likely unless the drug secures additional indications, develops novel delivery systems, or benefits from policy measures favoring branded drugs. Importantly, biosimilar proliferation in biologics markets exemplifies aggressive price articulation over time.
Impact of External Factors
- Policy and Regulation: Policy initiatives aiming at reducing healthcare costs can accelerate generic substitution, impacting prices downward.
- Market Demand Fluctuations: Changes in disease epidemiology, such as increased prevalence of target conditions, could stabilize or increase prices temporarily.
- Supply Chain Dynamics: Manufacturing costs, raw material availability, and supply disruptions influence pricing stability.
Key Takeaways
- NDC 00527-5511 operates within a highly competitive and regulated environment, with prices poised to decline sharply post-patent expiration.
- Market size and demand currently remain robust, particularly if the drug addresses prevalent conditions or holds exclusivity.
- Future prices will be primarily driven by generic entry, regulatory actions, and payer-driven formulary decisions.
- Stakeholders should closely monitor patent expiries, regulatory updates, and competitive developments to optimize market positioning.
- Innovative formulations or expanded indications could offset price erosion, maintaining revenue streams.
FAQs
Q1: How does patent expiration impact the pricing of NDC 00527-5511?
Patent expiration typically leads to the entry of generics, exerting downward price pressure. Prices for the original brand often decline by 40-60%, with further reductions as more competitors enter the market.
Q2: What are the primary factors influencing price projections for this drug?
Key factors include patent status, competitive landscape, therapeutic demand, regulatory changes, payer coverage, and manufacturing costs.
Q3: How can market entrants maintain profitability amidst declining drug prices?
Innovating with new formulations, expanding indications, or offering differentiated delivery methods can help sustain revenue despite price erosion.
Q4: Are biosimilars expected to influence the future price of biologic versions of the drug?
Yes. Biosimilar entry typically prompts significant price reductions, often 20-40% below branded biologics, depending on market dynamics and regional regulations.
Q5: What strategic considerations should manufacturers focus on to preserve market share?
Investments in post-marketing research, securing additional indications, engaging in strategic partnerships, and maintaining favorable payer relationships are crucial for market resilience.
References
[1] FDA National Drug Code Directory.
[2] IQVIA Institute Reports.
[3] SSR Health Data Reports.
[4] MarketResearch.com Pharmaceutical Reports.
[5] U.S. Patent and Trademark Office (USPTO) Publications.
More… ↓
